The data forecasts a steady increase in pancreas malignant neoplasms mortality in Canada from 2024 to 2028, starting at 5.68 thousand deaths in 2024 and rising to 6.02 thousand by 2028. Assuming the final actual data from 2023 was slightly lower, this represents a concerning trend. The year-on-year variations show increasing mortality, reflecting an average annual growth (CAGR) over this period.
Future trends to watch for include:
- Impact of healthcare advancements in early detection and treatment.
- Demographic changes, including aging population effects.
- National health policy responses to rising cancer mortality rates.
